Question Bank › The feared thing keeps not happening

The feared thing keeps not happening

The feared thing keeps not happening: management confronts a specific live worry with current evidence running against i

Calls Tested
994
Answered YES
93
Hit Rate
9.4%
rare by design

Magnite, Inc. (MGNI) — this company's answers

NO on the Q1 2022 call 2022-05-04 D
The model's full reasoning — Q1 2022 call → NO我们根据提供的财报电话会议记录,判断是否存在一个具体的、公司特定的负面担忧,并且管理层是否用已观察到的业务证据来反驳。 首先,寻找担忧。在电话会议中,分析师和公司管理层提到了几个担忧: - 关于SSP(卖方平台)的相关性,以及卖家直接连接买家的趋势(如The Trade Desk的OpenPass)可能威胁到Magnite的业务。管理层在开场白中直接回应了这一点,说“我们并不认为这些连接是威胁”,并认为SSP变得更有价值。这似乎是一个担忧,但管理层用论据反驳,而不是具体证据。 - 关于CTV增长和宏观逆风(如乌克兰危机、供应链问题)对业务的影响。管理层承认了这些逆风,但指出Q1结果符合预期,Q2指引强劲。 - 关于Disney+等新AVOD服务的影响,管理层认为这是积极的。 - 关于政治广告的潜在影响,管理层讨论了可能的置换效应,但认为总体是正面的。 - 关于The Trade Desk离开Google Open Bidding的影响,管理层说这对Magnite影响不大,因为OB本来就不是主要来源,而且资金可能流向了prebid。 - 关于平台整合(SpotX和Telaria合并)的进展,管理层说进展顺利。 但我们需要找到一个具体的、公司特定的担忧,并且管理层用已观察到的证据反驳。在记录中,有一个明显的担忧是:市场担心SSP会被绕过,卖家直接连接买家,导致SSP失去作用。管理层在开场白中直接回应了这一点,说“我们并不认为这些连接是威胁”,并认为SSP变得更有价值。但这是否有具体证据?管理层提到了“我们与GroupM的合作伙伴关系”作为例子,但那是宣布的,不是已观察到的行为。管理层还提到了“我们的客户更喜欢主要与Magnite合作”,但这是断言,没有具体数据。 另一个担忧是宏观逆风(乌克兰、供应链)对Q1的影响。管理层承认了这些逆风,但说Q1结果符合指引,Q2指引强劲。但这是否是“已观察到的证据”?管理层说“我们看到了同样的影响”,但然后说“我们看到了Q2的改善”,但那是预测,不是已发生的。 再仔细看,分析师的问题中,有关于OpenPass的担忧,管理层回应说“我们听到了很多来自出版商的消息”,但那是传闻,不是具体证据。关于CTV增长,管理层说“我们预计Q2 CTV收入在5100万到5300万”,那是指引,不是已发生的。 关键点:是否有分析师反复追问一个具体的负面结果,而管理层用已发生的业务事实来反驳?在记录中,分析师Laura Martin问关于CTV和Netflix/Disney添加广告层的影响,管理层说“没有坏处”,但那是观点。分析师Jason Kreyer问关于Q2指引的强劲,管理层解释了原因,但那是预测。 也许有一个担忧是:关于Disney+的合同续签。分析师Jason Kreyer问“关于Disney的关系,我们即将到期18个月的协议”,管理层说“关系仍然非常牢固,我们不认为会有实质性变化”,但那是信心,不是已观察到的证据。 另一个担忧是:关于The Trade Desk离开Open Bidding,分析师Matt Thornton问“早期影响”,管理层说“我们看到了资金流向prebid”,但那是观察到的吗?管理层说“我们看到了从Trade Desk通过OB的流量减少到涓涓细流”,那是已发生的,但那是关于竞争对手的行为,不是关于Magnite自己的业务。 也许有一个担忧是:关于CTV增长放缓。管理层在Q1说CTV pro forma增长27%,但那是过去的,不是担忧。 再读一遍问题:要求是“一个具体的负面结果,投资者、分析师或市场一直担心会发生在这家公司身上——这个担忧在电话会议上是活跃的,要么因为分析师反复追问,要么因为管理层自己提到这是别人持有的担忧——并且管理层通过指出当前、已经观察到的业务证据来反驳,表明所担心的结果到目前为止没有实现。” 在记录中,管理层在开场白中明确提到了一个担忧:“最近,有人质疑卖方平台的相关性,以及它可能在哪里适合一个卖家可以直接连接买家的世界。”管理层说“我们并不认为这些连接是威胁”,并说“我们看到它们表明SSP变得比以往任何时候都更有价值”。然后管理层用论据解释为什么SSP仍然重要,但有没有具体证据?管理层提到了“我们与GroupM的合作伙伴关系”作为例子,但那是宣布的,不是已发生的。管理层还提到了“我们的客户更喜欢主要与Magnite合作”,但那是断言。 另一个可能的担忧是:关于宏观逆风导致需求下降。管理层承认了乌克兰危机的影响,但说Q1结果符合指引,Q2指引强劲。但那是预测,不是已发生的。 也许有一个担忧是:关于CTV增长放缓,但管理层说“我们预计Q2 CTV收入在5100万到5300万”,那是指引。 再仔细看,分析师的问题中,有关于“OpenPass”的担忧,管理层回应说“我们听到了很多来自出版商的消息”,但那是传闻。 也许有一个担忧是:关于“Disney+”的合同续签,管理层说“关系仍然非常牢固”,但那是信心。 似乎没有一个具体的、公司特定的担忧被管理层用已观察到的证据反驳。管理层更多是提供论据和预测,而不是引用已发生的业务事实。 但让我们再检查一下:在Q&A中,分析师Jason Kreyer问“关于Q2指引的强劲”,管理层解释了原因,包括“我们看到了一些垂直领域的加强”,但那是观察到的吗?管理层说“我们看到了一些垂直领域的加强”,但那是模糊的。 另一个分析师问“关于政治广告”,管理层说“我们看到了历史”,但那是历史。 也许有一个担忧是:关于“The Trade Desk离开Open Bidding”,管理层说“我们看到了从Trade Desk通过OB的流量减少”,但那是关于竞争对手的,不是关于Magnite自己的业务。 再读一遍问题:要求是“公司特定的担忧

← Back to the full MGNI analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, is there a SPECIFIC NEGATIVE OUTCOME that investors, analysts, or the market have plainly been worried will happen to THIS company — a worry that is live on this call, evident either because analysts keep probing it or because management itself names it as a concern others hold — AND does management push back on that worry by pointing to CURRENT, ALREADY-OBSERVED evidence from the business showing that the feared outcome is, so far, NOT materializing? Answer YES when BOTH halves come through in the transcript as one coherent dynamic, in whatever form fits the business: (1) A NAMED, COMPANY-SPECIFIC FEAR THAT IS LIVE NOW. The worry is concrete and attached to this company — for example: that demand will fall off after an unusually strong stretch; that a major customer, contract, or partner will shrink, leave, or not renew; that a competitor, new technology, or cheaper alternative will take the company's business; that a key product, franchise, or pricing level is about to erode; that recent growth is a one-time bulge that will reverse; or another identifiable adverse outcome the market has been bracing for. The fear must be visible on the call itself — analysts returning to it in their questions, or management acknowledging in its own words that this is what people are worried about — not merely a generic risk factor or ordinary caution. (2) MANAGEMENT ANSWERS WITH OBSERVED BEHAVIOR, NOT REASSURANCE. Management responds by citing things that have ALREADY HAPPENED or are happening now — customers renewing, reordering, or expanding when they were expected to leave; demand holding or growing through the period when a drop-off was predicted; the threatened product, customer, or pricing actually performing in the recent period; competitive losses that have not shown up in real accounts; the feared cliff period arriving and being cleared — described with enough concrete substance (who, what, how much, or compared to when) that the rebuttal rests on evidence from the business rather than on confidence, promises, arguments about why the fear is illogical, or projections that the future will be fine. Answer NO if no specific company-attached worry is visible on the call — a routinely healthy company fielding ordinary questions is not this. Answer NO if the fear is visible but management's response is mainly reassurance, optimism, plans, or forecasts without already-observed evidence against it. Answer NO if the evidence shows the feared outcome IS materializing and management is excusing, minimizing, or promising to fix it. Answer NO if the worry is only broad macro or industry-wide gloom with nothing specific to this company's own business. Answer NO if management concedes the fear is valid and pivots to a different story instead of countering it. Answer NO if the counter-evidence is only a single vague assertion (such as 'demand remains strong') with no concrete grounding in what has actually occurred. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
AVTR Avantor, Inc. Q2 2024 2024-07-26 C+
IFS Intercorp Financial Services Inc. Q1 2024 2024-05-14 C+
AZEK The AZEK Company Inc. Q2 2024 2024-05-08 B+
GL Globe Life Inc. Q1 2024 2024-04-23 F
MNKD MannKind Corporation Q4 2023 2024-02-27 C
NICE NICE Ltd. Q4 2023 2024-02-22 B+
TYGO Tigo Energy, Inc. Q4 2023 2024-02-14 F
MET MetLife, Inc. Q4 2023 2024-02-01 B+
BBVA Banco Bilbao Vizcaya Argentaria, S.A. Q4 2023 2024-01-30 B+
TBLA Taboola.com Ltd. Q3 2023 2023-11-08 B+
GMED Globus Medical, Inc. Q3 2023 2023-11-07 B
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
MAC The Macerich Company Q3 2023 2023-10-31 D
LNTH Lantheus Holdings, Inc. Q2 2023 2023-08-03 C+
SITM SiTime Corporation Q2 2023 2023-08-02 C+
TREX Trex Company, Inc. Q2 2023 2023-07-31 B+
REYN Reynolds Consumer Products Inc. Q1 2023 2023-05-10 C
DOCN DigitalOcean Holdings, Inc. Q1 2023 2023-05-09 C+
ULCC Frontier Group Holdings, Inc. Q1 2023 2023-05-07 C+
AKR Acadia Realty Trust Q4 2022 2023-05-06 B+
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
EPR EPR Properties Q1 2023 2023-04-27 C+
MEDP Medpace Holdings, Inc. Q1 2023 2023-04-25 B+
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
CRBG Corebridge Financial, Inc. Q4 2022 2023-02-22 B
POOL Pool Corporation Q4 2022 2023-02-16 C+
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
REGN Regeneron Pharmaceuticals, Inc. Q4 2022 2023-02-03 C
HBAN Huntington Bancshares Incorporated Q4 2022 2023-01-20 B
A Agilent Technologies, Inc. Q4 2022 2022-11-21 B+
PCTY Paylocity Holding Corporation Q1 2023 2022-11-05 A
TT Trane Technologies plc Q3 2022 2022-11-02 A
APOG Apogee Enterprises, Inc. Q2 2023 2022-09-20 A
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
SGRY Surgery Partners, Inc. Q2 2022 2022-08-02 B+
ZBRA Zebra Technologies Corporation Q2 2022 2022-08-02 C+
LIN Linde plc Q2 2022 2022-07-28 B+
SHW The Sherwin-Williams Company Q2 2022 2022-07-27 D
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
KFY Korn Ferry Q4 2022 2022-06-22 B
SE Sea Limited Q1 2022 2022-05-17 F
DCGO DocGo Inc. Q1 2022 2022-05-14 C
ZVIA Zevia PBC Q1 2022 2022-05-12 B
EGHT 8x8, Inc. Q4 2022 2022-05-10 C+
CCRN Cross Country Healthcare, Inc. Q1 2022 2022-05-04 B
ABNB Airbnb, Inc. Q1 2022 2022-05-03 B+
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
BSX Boston Scientific Corporation Q1 2022 2022-04-27 B
CCK Crown Holdings, Inc. Q1 2022 2022-04-26 C+
FR First Industrial Realty Trust, Inc. Q1 2022 2022-04-21 A
SDIG Stronghold Digital Mining, Inc. Q3 2021 2021-11-30 F
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
IPGP IPG Photonics Corporation Q3 2021 2021-11-02 C
HSY The Hershey Company Q3 2021 2021-10-28 C
PEP PepsiCo, Inc. Q3 2021 2021-10-05 B
GDS GDS Holdings Limited Q2 2021 2021-08-17 C+
PTVE Pactiv Evergreen Inc. Q2 2021 2021-08-08 C+
SPG Simon Property Group, Inc. Q2 2021 2021-08-02 B
GLW Corning Incorporated Q2 2021 2021-07-27 B+
DOV Dover Corporation Q2 2021 2021-07-20 B+
VLRS Controladora Vuela Compañía de Aviación, Q2 2021 2021-07-16 B+
MAR Marriott International, Inc. Q2 2018 2018-08-07 B
VALE Vale S.A. Q2 2018 2018-07-26 B
FICO Fair Isaac Corporation Q3 2018 2018-07-26 C+
ORAN Orange SA Q2 2018 2018-07-26 B
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
TRUE TrueCar, Inc. Q1 2018 2018-05-08 C
TGNA TEGNA Inc. Q1 2018 2018-05-08 B+
CVS CVS Health Corporation Q1 2018 2018-05-02 B+
ALLY Ally Financial Inc. Q1 2018 2018-04-26 B+
MIDD The Middleby Corporation Q4 2017 2018-02-28 C
SBUX Starbucks Corporation Q1 2018 2018-01-26 C
AVT Avnet, Inc. Q2 2018 2018-01-25 B
GURE Gulf Resources, Inc. Q3 2017 2017-11-14 F
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
MKTX MarketAxess Holdings Inc. Q3 2017 2017-10-25 C+
PII Polaris Inc. Q3 2017 2017-10-24 C+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
BCRX BioCryst Pharmaceuticals, Inc. Q1 2017 2017-05-07 B
ICFI ICF International, Inc. Q1 2017 2017-05-06 B+
CGNT Cognyte Software Ltd. Q4 2016 2017-03-09 D
BDC Belden Inc. Q4 2016 2017-02-02 B
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+
TGI Triumph Group, Inc. Q2 2017 2016-11-03 C+
SEM Select Medical Holdings Corporation Q1 2016 2016-05-06 C+
LPSN LivePerson, Inc. Q1 2016 2016-05-04 B
UVE Universal Insurance Holdings, Inc. Q1 2016 2016-05-03 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
VRTS Virtus Investment Partners, Inc. Q1 2016 2016-04-29 D
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
BX Blackstone Inc. Q1 2016 2016-04-21 B
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

TGI · Q2 2017 → YESThe question is: Is there a specific negative outcome that investors/analysts/market are worried about for THIS company, live on this call, and does management push back with CURRENT, ALREADY-OBSERVED...YES The specific, company-attached fear that is live on the call is that Triumph will continue to face large performance-related charges, cash burn on development programs, and failure to stabilize margins/cash flow despite the transformation (a worry analysts repeatedly probe via questions on the $80M risk, free-cash-use guidance, 747-8/C-17/G650 headwinds, and red programs). Management directly counters it by citing already-observed evidence: Q2 operating income of $70.
ULCC · Q1 2023 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors/analysts/market have been worried about for THIS company, live on this call, AND does management push back with CURRENT, ALREADY-OB...YES The transcript shows a live, company-specific worry about pilot staffing shortages (tied to network changes and new contracts elsewhere) and customer churn/retention due to lower satisfaction scores. Management directly counters both with current evidence: pilot surplus and attrition on target for staffing, plus over 90% repeat business for retention.
HOLX · Q4 2017 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors, analysts, or the market have plainly been worried will happen to THIS company, and does management push back on that worry by poin...YES The transcript shows a live, company-specific fear centered on Cynosure: investors and analysts are worried that the acquisition will not deliver sustainable growth, that recent sequential declines reflect a lasting salesforce collapse or competitive erosion, and that the business will continue underperforming expectations rather than turning around.

More from the question bank

Doors opening at the company's own gatesReporting the counterparty's growth as its oSecond proving already underwayNew normal declared and staffedBigger than they can carry aloneDemand arrived first, the company is growingAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.